Quantcast
Home > Quotes > LMNX
LMNX

Luminex Corporation Common Stock (LMNX) Quote & Summary Data

$26.54
*  
0.47
1.74%
Get LMNX Alerts
*Delayed - data as of Nov. 19, 2018  -  Find a broker to begin trading LMNX now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    LMNX Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
28.5
Today's High / Low
$ 27.31 / $ 26.29
Share Volume
200,609
50 Day Avg. Daily Volume
288,552
Previous Close
$ 27.01
52 Week High / Low
$ 35.37 / $ 18.62
Market Cap
1,183,153,386
P/E Ratio
66.35
Forward P/E (1y)
45.76
Earnings Per Share (EPS)
$ 0.40
Annualized Dividend
$ .24
Ex Dividend Date
9/20/2018
Dividend Payment Date
10/12/2018
Current Yield
0.89 %
Beta
1.1

Intraday Chart

Shares Traded

Share Volume:
200,609
50 Day Avg. Daily Volume:
288,552

P/E Ratio

P/E Ratio:
66.35
Forward P/E (1y):
45.76
Earnings Per Share (EPS):
$ 0.40

Trading Range

The current last sale of $26.54 is 42.53% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 27.31 $ 35.37
 Low: $ 26.29 $ 18.62

ETFs with LMNX as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
1.86% First Trust Small Cap US Equity Select ETF (RNSC) -0.49 (-2.26%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

We develop, manufacture and sell proprietary biological testing technologies and products with applications throughout the life sciences industries, including diagnostics, pharmaceutical and research. These industries depend on a broad range of tests, called assays, to perform diagnostic testing and conduct life science research. We have established a position in several segments of the life sciences industries by developing and delivering products that satisfy a variety of customer needs in specific market segments, including multiplexing, accuracy, precision, sensitivity, specificity, reduction of labor and ability to test for proteins and nucleic acids. These needs are addressed by our proprietary technologies. Multiplexing, the foundation of our Company, allows the end user in a laboratory to generate multiple laboratory results from a single sample with a single assay.  ... More ...  


Risk Grade

Where does LMNX fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 27.04
Open Date:
Nov. 19, 2018
Close Price:
$ 26.54
Close Date:
Nov. 19, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x